Comparative Analysis of Dimethyl Fumarate and Teriflunomide in Relapsing Remitting Multiple Sclerosis.
Jannis MüllerSabine SchädelinJohannes LorscheiderPascal BenkertPeter HänniJürg SchmidJens KuhleTobias DerfussCristina GranzieraÖzgür YaldizliPublished in: European journal of neurology (2023)
Analysis of real-world data showed that dimethyl fumarate treatment was associated with more favorable outcomes than teriflunomide.